D. Hess

发表

Models for Central Nervous System Complications of Antiphospholipid Syndrome

D. Hess, 1994, Lupus.

Immediate and Near Future Prediction of COVID-19 Patients in the U.S. Population Aged 65+ With the Prior Medical Conditions of Hypertension, Cardiovascular and Lung Diseases: Methods, Models and Acute Care Estimates

Arni S. R. Srinivasa Rao, S. Krantz, A. Berman, 2020, medRxiv.

Prevalence of dystonia in veterans on chronic antipsychotic therapy

K. Sethi, D. Hess, Rollie Harp, 1990, Movement disorders : official journal of the Movement Disorder Society.

COVID-19 and neurological symptoms: is the SARS-CoV-2 virus neurotropic?

J. Morgan, Elizabeth Rutkowski, L. McCluskey, 2020, Conditioning medicine.

Remote Ischemic Conditioning: Feasible and Potentially Beneficial for Ischemic Stroke.

G. Andersen, R. Blauenfeldt, D. Hess, 2022, JAMA.

A County-Level Analysis of Socioeconomic and Clinical Predictors of COVID-19 Incidence and Case-Fatality Rates in Georgia, March–September 2020

A. Berman, D. Rahn, Elias Mossialos, 2021, Public health reports.

Orthostatic paroxysmal dystonia

K. Sethi, D. Hess, K. Lee, 2002, Movement disorders : official journal of the Movement Disorder Society.

Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA

J. Switzer, J. Morgan, S. Su, 2022, Brain, Behavior, & Immunity - Health.

Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment.

Jack C. Yu, B. Baban, J. Morgan, 2021, Cannabis and cannabinoid research.

Altered mental status is an independent predictor of mortality in hospitalized COVID-19 patients

Daniel F. Linder, Jack D Owens, P. Shah, 2021, Irish Journal of Medical Science (1971 -).

A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome

Jack C. Yu, B. Baban, J. Morgan, 2021, Journal of Cannabis Research.

The time dimension to stroke: Circadian effects on stroke outcomes and mechanisms

K. Dhandapani, P. Kamat, Mohammad B. Khan, 2022, Neurochemistry International.

Stem cells and neurological diseases

C. Borlongan, D. Hess, Cesario V. Borlongan, 2007, Cell proliferation.

Conditioning medicine for ischemic and hemorrhagic stroke.

B. Baban, P. Kamat, G. Andersen, 2021, Conditioning medicine.

The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results

L. McCullough, D. Thedens, C. Ayata, 2022, Stroke.

Exercise Improves Cerebral Blood Flow and Functional Outcomes in an Experimental Mouse Model of Vascular Cognitive Impairment and Dementia (VCID)

B. Baban, A. Arbab, Mohammad B. Khan, 2023, Translational stroke research.

Inflammaging and Cannabinoids

Jack C. Yu, B. Baban, V. Costigliola, 2021, Ageing Research Reviews.

Comparative Neuroimaging With Pathologic Correlates in Alexander's Disease

D. Hess, R. Figueroa, A. Fischer, 1990, Journal of child neurology.

Creutzfeldt‐Jakob's disease presenting with ataxia and a movement disorder

K. Sethi, D. Hess, 1991, Movement disorders : official journal of the Movement Disorder Society.

Cell therapy for ischaemic stroke

D. Hess, W. Hill, D. Hess, 2011, Cell proliferation.

Pharmacology and clinical experience with simvastatin

S. Fagan, D. Hess, David C. Hess, 2001, Expert opinion on pharmacotherapy.

Profound racial disparities in COVID-19 associated hospitalizations in rural Southwest Georgia

J. Moore, Jack D Owens, P. Shah, 2021, The American Journal of the Medical Sciences.

Transplantation of post‐mitotic human neuroteratocarcinoma‐overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: In vitro evidence of expedited neuronal differentiation and GDNF secretion

T. Kawase, T. Yasuhara, C. Borlongan, 2007, Journal of neuroscience research.

Inhalant cannabidiol impedes tumor growth through decreased tumor stemness and impaired angiogenic switch in NCI-H1437-induced human lung cancer model

Jack C. Yu, B. Baban, S. Deb, 2023, Human Cell.

Establishment of an internationally agreed minimum data set for acute telestroke

C. Watkins, L. Schwamm, T. Ingall, 2020, Journal of telemedicine and telecare.

Acetazolamide treatment of paroxysmal dystonia in central demyelinating disease

R. Adams, K. Sethi, D. Hess, 1992, Neurology.

Recycled Translation: Repurposing Drugs for Stroke

Samantha E. Spellicy, D. Hess, 2022, Translational Stroke Research.

Repurposing an Old Drug to Improve the Use and Safety of Tissue Plasminogen Activator for Acute Ischemic Stroke: Minocycline

S. Fagan, D. Hess, 2010, Pharmacotherapy.

Laboratory and clinical research on COVID-19: focus on non-lung organs.

C. Borlongan, D. Hess, 2020, Conditioning medicine.

A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke

J. Mandeville, C. Ayata, F. Hyder, 2023, Science Translational Medicine.

Remote Ischemic Conditioning: Challenges and Opportunities

X. Ji, D. Yellon, D. Hausenloy, 2023, Stroke.

Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease 2019 Patients Experiencing In-Hospital Cardiac Arrest?

J. Moore, Jack D Owens, P. Shah, 2020, Critical care medicine.